PITTSBURGH--(BUSINESS WIRE)--Evoqua Water Technologies (NYSE: AQUA) today announced Peter M. Wilver,
former senior executive at Thermo Fisher Scientific Inc. (NYSE: TMO),
has joined its Board as an independent director and chair of the
Company’s Audit Committee.
Wilver brings a wealth of industrial products and M&A experience along
with strong financial acumen to Evoqua’s Board. He previously served 11
years as Chief Financial Officer of Thermo Fisher Scientific, a publicly
traded life sciences technology company, during a period of significant
profitable growth for the company. Most recently, he served as Thermo
Fisher’s Executive Vice President and Chief Administrative Officer.
Earlier in his career, Wilver held financial management roles at
industrial companies including GE, Honeywell and Grimes Aerospace.
Wilver is also a member of the Board of Directors of CIRCOR
International, Inc. (NYSE: CIR), an industrial manufacturer serving the
oil and gas, petrochemical, power generation and aviation markets and
Tenet Healthcare Corporation (NYSE: THC), a healthcare services company
operating acute care hospitals and outpatient centers and providing
health management solutions. He also serves on the Advisory Board of
Letter One Health, an investment firm focused on acquisition
opportunities that occupy a critical and strategic role in the
healthcare value chain.
“Throughout his career, Pete has helped lead major profitable growth
efforts – he was a key member of the team that built Thermo Fisher
Scientific from $3 billion to $18 billion in revenue – and he has
completed and integrated more than $35 billion in acquisitions
throughout his career,” said Ron Keating, Evoqua Chief Executive
Officer. “Pete has established an impressive track record of strategic,
financial and commercial accomplishments and has proven to be a
successful and trusted leader. His wealth of experience will be
invaluable to the Audit Committee and to Evoqua Water Technologies as a
whole.”
“Having recently completed its successful IPO, it is an exciting time to
join the Evoqua Board and be a part of this growth company,” said
Wilver. “I look forward to being a part of a company at the leading edge
of sustainability and that works with more than 38,000 customers across
the globe to Transform Water and Enrich Lives.”
Evoqua Water Technologies
Evoqua Water Technologies (NYSE: AQUA) is a leading provider of mission
critical water treatment solutions, offering services, systems and
technologies to support its customers’ full water lifecycle needs.
Evoqua Water Technologies has worked to protect water, the environment
and its employees for more than 100 years, earning a reputation for
quality, safety and reliability around the world. Headquartered in
Pittsburgh, Pennsylvania, Evoqua operates 160 locations in eight
countries and, with over 200,000 installations and 87 service branches,
holds leading positions in the North American industrial, commercial and
municipal water treatment markets, serving more than 38,000 customers
worldwide. Visit www.evoqua.com
Forward Looking Statement
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. All of
these forward-looking statements are based on our current expectations,
assumptions and estimates. While we believe these expectations,
assumptions and estimates are reasonable, such forward-looking
statements are only predictions and involve known and unknown risks and
uncertainties, many of which are beyond our control. These and other
important factors may cause our actual results, performance or
achievements to differ materially from any future results, performance
or achievements expressed or implied by these forward-looking
statements, or could affect our share price. Additionally, this press
release speaks only as of its date. We undertake no obligation to update
or revise, or to publicly announce any update or revision to, any of the
forward-looking statements made herein, whether as a result of new
information, future events or otherwise. These forward-looking
statements should not be relied upon as representing the Company’s views
as of any date subsequent to January 9, 2018.